Research NewsletterIssue: ORN-2024-09

Recent NJIT Patents Issued by US Patent and Trademark Office (USPTO)

Recent NJIT Non-Provisional Patent Applications (Submitted)

Issued Patent

Patent Title: Fluidic Impedance Platform for In-Situ Detection and Quantification of PFAS in Groundwater

NJIT Ref No.:  19-014 

Patent No.:  11,891,313

Inventor(s): Basuray, Sagnik ; Motkury, Radha / Chatterjee, Sayandev / Cheng, Hsuan

Patent Application Status:  Issued Patent 

Patent Issue Date:  2/6/24

Status: Jointly owned with Battelle Memorial Institute Inc

Filed NonProvisional Patent Application

Patent Title: A Non-Volatile Processing-In-Sensor Accelerator for Imaging Systems

NJIT Ref No.:  23-013

Patent Application No.:  18/439,267

Inventor(s): Angizi, Shaahin / Roohi, Arman

Patent Application Status: Non-Provisional Patent Application; Jointly filed with the University of Nebraska 

Non-Provisional Patent Application Filing Date:  2/12/2024

____________________________________

NIH Blueprint MedTech

Blueprint MedTech Funding Opportunities

Innovators developing groundbreaking medical device technologies face a number of challenges along the translational path from bench to bedside. The Blueprint MedTech program is an NIH incubator that aims to address such challenges and support the innovators by accelerating the development of cutting-edge medical devices to diagnose and/or treat disorders of the nervous system. The mission of the program is to catalyze the translation of novel technologies from early-stage development to readiness for first-in-human clinical studies. The program will provide: (a) non-dilutive funds to support medical device development activities led by investigators, and (b) additional resources and support services including, but not limited to:

• Planning resources to support concept development, team building, needs assessment, and other early translational activities.
• Streamlined access to translational services and expertise (e.g., design and prototyping, bench testing, large animal testing, biocompatibility assessment, manufacturing, medical monitoring).
• Assistance from consultants (e.g., on regulatory, reimbursement, intellectual property, commercialization, and strategic partnership issues).
• Advice from industry experts (e.g., meetings with an external oversight committee).

The overarching goal of the Blueprint MedTech program is to accelerate patient access to groundbreaking, safe, and effective medical devices. The program will provide support to sufficiently develop and de-risk technologies to the point where additional investments are warranted from industry partners, investors, and government.

CIMIT’s CINTA and NeuroTech Harbor, through the NIH Blueprint MedTech program, are excited to announce our fourth funding opportunity. Submit your pre-proposal by February 29th for awards aimed at accelerating medtech solutions that address challenges associated with disorders of the nervous system. 

NSF: Ideas Lab: Use-Inspired Acceleration of Protein Design; Next Era of Wireless and Spectrum; Plant Genome Research Program; Division of Integrative Organismal Systems Core Programs; Ideas Lab: Breaking the Low Latency Barrier for Verticals in Next-G Wireless Networks; Developmental Sciences; Division of Environmental Biology; Multi-Messenger Coordination for Windows on the Universe; ACED: Accelerating Computing-Enabled Scientific Discovery; Established Program to Stimulate Competitive Research (EPSCoR) Workshop Opportunities; Division of Molecular and Cellular Biosciences Core Programs; Partnerships for Innovation (PFI)

NIH: Translational Neural Devices (R61/R33 - Clinical Trial Optional)

Department of Defense/US Army/DARPA/ONR: FY25 Department of Defense Multidisciplinary Research Program of the University Research Initiative (MURI); Distributed Analytics in Tactical Networks; FY25 Young Investigator Program

Department of Energy: Research on General Plasma Science Collaborative Research Facilities; Flexible and Innovative Transformer Technologies (FITT); Advancements in Artificial Intelligence for Science; Fiscal Year 2024 Technology Integration (TI) Funding Opportunity Announcement

NASA: ROSES - 2024: Early Career Investigator Program and Other Solicitations

DOD’s generative AI task force looks for ‘blind spots’: Understanding the limitations of artificial intelligence technology is key to the Department of Defense’s broader adoption of emerging tools, according to the head of the Pentagon’s task force for exploring how generative AI technologies can be safely used for military operations. During a presentation at the Chief Digital and Artificial Intelligence Office’s defense data and AI symposium on Thursday, U.S. Navy Captain Manuel Xavier Lugo said the DOD initiative, known as Task Force Lima, is focused on understanding “the areas where people want to utilize these technologies.” DOD launched the task force in August with the goal of “harnessing the power of artificial intelligence in a responsible and strategic manner.” Since then, the initiative has collected more than 180 use cases across the Pentagon to determine the capabilities of these tools. More information is posted on the NextGov website.

____________________________

NIST inks partnership to put safety at the intersection of AI and genetic research: The federal government took a new step Friday in addressing the potentially hazardous intersections of emerging technologies: artificial intelligence and biotechnology.  The National Institute of Standards and Technology inked a new partnership with the nonprofit Engineering Biology Research Consortium to help develop effective safety tools specifically aimed at preventing the misuse of advanced AI when leveraged to synthesize DNA and RNA  – the building blocks of cells. Synthetic nucleic acids are manufactured outside of cells with the help of chemical processes.  Biotechnical applications for synthetic nucleic acids are advanced, and researchers have used them to develop novel medical therapies and drugs, as well as in agricultural research.   The new collaboration, required under President Joe Biden’s October 2023 executive order on AI, will work toward developing best practices, standards and implementation guidance for synthesizing nucleic acids to prevent misuse when leveraging generative AI software to sift through data and help develop these solutions. More information is posted on the NextGov website.

____________________________

DOD's AI strategy leans on high-quality data: Positioning high-quality data as the foundation of the Department of Defense’s work to scale artificial intelligence technologies across its mission will require significant partnerships with the private sector, the head of the Pentagon's Chief Digital and Artificial Intelligence Office — or CDAO — said on Tuesday.  During a keynote address at CDAO’s defense data and AI symposium, Chief Digital and Artificial Intelligence Officer Craig Martell said his office is trying to strike a delicate balance between providing tools for “the fight tonight” and long-term efforts to adopt interoperable technologies and more holistic automated solutions across DOD.  While Martell said DOD could simply “contract out a stovepipe solution” that does not use high-quality data to address some of its immediate needs, he said that “data quality is the most important aspect” of the department’s long-term adoption of AI technologies — particularly when it comes to streamlining solutions across the various combatant commands.  DOD’s data, analytics and AI adoption strategy — developed by the CDAO and publicly released last November — placed quality of data as the base of the department’s overarching “AI hierarchy of needs.” More information is posted on the NextGov website.